Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer [Phase 1, Phase 2]
Clinical trial evaluating adjuvant proton therapy or IMRT for bladder cancer has completed (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Intravesical BCG Administration to Patients With Invasive Bladder Cancer [NA]
Clinical trial update on intravesical BCG administration for invasive bladder cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function [Phase 2]
Phase 2 trial evaluating vinflunine in patients with metastatic bladder cancer and impaired renal function has completed.
-
FDA approval · 2019-10-03FDA Approved: GEMCITABINE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for gemcitabine hydrochloride from Gland Pharma Limited. This approval enables the marketing of …
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 neoadjuvant dose-dense gemcitabine and cisplatin trial in muscle-invasive bladder cancer completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-09-19Clinical Trial Update: Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers [NA]
Clinical trial update evaluating the appeal and impact of e-cigarettes among chronic smokers with smoking-related cancers; study completed w…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer [Phase 2]
Phase 2 trial evaluating ACP-196 (calquentinib) in combination with pembrolizumab for metastatic urothelial carcinoma has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors [Phase 2]
Phase 2 trial updating on trastuzumab emtansine in HER2-overexpressing solid tumors has completed; results posted in 2019.
-
CLINICAL_TRIALS research · 2019-08-28Clinical Trial Update: Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers [Phase 2]
Phase 2 trial evaluating ferumoxytol-enhanced MRI for detecting lymph node metastases in prostate, bladder, and kidney cancers; study comple…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression [Phase 1]
Phase 1 study of ADCT-502 in HER2-expressing advanced solid tumors including breast cancer and non-small cell lung cancer has terminated wit…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery [Phase 2]
Phase 2 trial evaluating chemotherapy and radiation therapy in stage II/III bladder cancer patients post-surgery; results posted after compl…
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating paclitaxel-binding albumin and cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Near Infrared Fluorescence Imaging for Bladder Cancer Detection [NA]
Completed clinical trial investigating near infrared fluorescence imaging for detection of bladder cancer; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Photodynamic Diagnosis (PDD) in Flexible Cystoscopy [Phase 3]
Phase 3 trial investigating Photodynamic Diagnosis (PDD) in flexible cystoscopy for bladder cancer recurrence has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer [Phase 1]
Phase 1 trial evaluating enzalutamide with gemcitabine and cisplatin in bladder cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Investigation of Sugammadex in Outpatient Urological Procedures [Phase 4]
Phase 4 clinical trial evaluating sugammadex in outpatient urological procedures has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Biological Therapy in Treating Patients With Bladder Cancer [Phase 3]
Phase 3 clinical trial update evaluating a biological therapy for bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection [NA]
A clinical trial investigating sequential intravesical BCG and electromotive mitomycin-C after transurethral resection for bladder carcinoma…
-
CLINICAL_TRIALS withdrawal · 2019-06-12Clinical Trial Update: Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer [Phase 3]
A Phase 3 trial investigating rapamycin for secondary prevention in patients with resected non-muscle invasive bladder cancer has been withd…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis [Phase 2]
A Phase 2 trial update on IMUNO BGC Moreau RJ for prophylaxis in high-risk non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive [Phase 1, Phase 2]
Clinical trial update for a T cell receptor therapy targeting MAGE-A3 in HLA-A*01 positive patients with metastatic cancer; the study is ter…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and gemcitabine with or without vandetanib as first-line therapy for locally advanced or metastatic uri…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Sunitinib in Treating Patients With Locally Advanced Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating sunitinib in patients with locally advanced bladder cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer [Phase 3]
Phase 3 trial evaluating continuous infusion of ropivacaine hydrochloride to reduce postoperative pain after bladder cancer surgery was with…
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Alisertib in Chemotherapy-pretreated Urothelial Cancer [Phase 2]
Phase 2 trial of alisertib in chemotherapy-pretreated urothelial/bladder cancer has completed.